Peter McPartland

Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom.

Martlet Capital (Marlet Capital) is a venture capital subsidiary of Marshall of Cambridge (Holdings) Ltd founded in 2011 by Peter Lawton Cowley and Robert Marshall. The firm is headquartered in Cambridge, United Kingdom.

GKMH Ltd. is a company based in Newmarket, UK. The British company was founded in 2019.

Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC.

Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov.

SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.

Forte Medical Ltd. operates as a specimen collection company. It manufactures and sells medtech devices. The company was founded by Vincent John Charles Forte and Giovanna Forte and is headquartered in London, the United Kingdom.